IP Library Granted Patent US 11,896,282
Granted Patent B2
US 11,896,282 · App. 16/247,404 · Granted Feb 13, 2024

Tissue ablation systems and method

Inventors: Akos Toth (Cupertino, CA); Csaba Truckai (Saratoga, CA)
Assignee: HERMES INNOVATIONS LLC
A61B18/042A61B18/1206A61B18/1492A61B2018/00577A61B2018/00589A61B2018/00702A61B2018/00791A61B2018/00875A61B2018/122
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,896,282
App. No.
16/247,404
Granted
Feb 13, 2024
Kind
B2
Abstract

Tissue is treated using a radiofrequency power supply connected to an applicator having a chamber filled with an electrically non-conductive gas surrounded by a thin dielectric wall. A radiofrequency voltage is applied at a level sufficient to ionize the gas into a plasma and to capacitively couple the ionized plasma with the tissue to deliver radiofrequency current to ablate or otherwise treat the tissue.

Claims (35)

1. A system for applying energy to tissue comprising:

a probe having an energy-delivery surface configured for spatiotemporal switching of focal points of energy application about the surface in contact with tissue;

a gas-filled chamber interior of the energy-delivery surface; and

voltage source configured for creating transitory plasma streamers within the gas-filled chamber to thereby provide spatial and temporal switching of energy coupling to the focal points.

2. The system of claim 1 , wherein the gas-filled chamber includes a near-atmospheric pressure range gas.

3. The system of claim 1 , wherein the gas-filled chamber includes a noble gas or mixture of noble gases.

4. The system of claim 1 , wherein the voltage source is configured to provide a voltage that reduces spatiotemporal chaos.

5. The system of claim 1 , wherein the voltage source is configured to provide a voltage that eliminates spatiotemporal chaos.

6. The system of claim 1 , wherein the voltage source is configured to provide a voltage of at least 100 volts.

7. The system of claim 1 , wherein the energy-delivery surface comprises a dielectric material.

8. The system of claim 1 , further comprising:

a first electrode positioned at an exterior of the energy-delivery surface; and

a second electrode positioned within an interior of the gas-filled chamber; and

the voltage source is configured to provide a voltage between the first electrode and the second electrode to create the plasma streamers.

9. A system for applying energy to tissue, comprising:

a probe including a dielectric material defining; a gas-filled Chamber, the dielectric material including an inner surface configured for gas contact with gas within the gas-filled chamber and an outer surface configured for tissue contact, the dielectric material configured for spatiotemporal switching of focal points of energy application;

an interior electrode disposed within the gas-filled chamber;

an exterior electrode disposed outside of the gas-filled chamber;

a voltage source configured to provide a voltage between the interior electrode and the exterior electrode, thereby creating transitory plasma streamers within the gas-filled chamber in order to provide spatial and temporal switching of energy coupling to the focal points; and

a controller configured to control the voltage source.

10. The system of claim 9 , further comprising a gas inlet and a gas outlet each fluidly coupled with an interior of the gas-filled chamber in order to provide a gas flow through the gas-filled chamber.

11. The system of claim 10 , wherein the controller is further configured to control the gas flow through the gas-filled chamber.

12. The system of claim 9 , wherein the controller is further configured to limit spatiotemporal chaos of the plasma streamers.

13. The system of claim 9 , wherein the controller is further configured to spatiotemporally control the plasma streamers.

14. The system of claim 9 , wherein the controller is further configured to create a spatiotemporal pattern of plasma streamers.

15. The system of claim 14 , Wherein the controller is further configured to control electrostatic lines of flux.

16. The system of claim 9 , wherein the voltage source is configured to provide a voltage of at least 100 volts.

17. The system of claim 9 , wherein the gas within the gas-filled chamber comprises argon.

18. A system for applying energy to tissue, comprising:

a gas-filled chamber including an inner surface configured for contact with gas within the gas-filled chamber and an outer surface configured for tissue contact, the gas-filled chamber formed of a dielectric material configured for spatiotemporal switching of focal points of energy application;

a first electrode disposed within the gas-filled chamber;

a second electrode disposed outside of the gas-filled chamber; and

a voltage source configured to provide a voltage between the first electrode and the second electrode, thereby creating transitory plasma streamers within the gas-filled chamber in order to provide spatial and temporal switching of energy coupling to the focal points.

19. The system of claim 18 , wherein the voltage source is configured to provide a voltage that reduces spatiotemporal chaos.

20. The system of claim 18 , wherein the gas-filled chamber is filled with argon.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 12, 2026
From: MINERVA SURGICAL, INC.
To: AXORA MEDICAL, INC.
Reel/Frame 075561/0141 →